Edwards Lifesciences Corp (EW)

↓ Download CSV

CIK 0001099800 · NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, Edwards Lifesciences Corp reported revenue of $6.07B, up 11.5% from the prior year. The company was profitable, with a net margin of 17.6% and a gross margin of 78.0%. It held $13.70B in total assets against $3.36B in total liabilities.

Key ratios (FY2025)

78.0%
Gross margin
20.8%
Operating margin
17.6%
Net margin
10.3%
Return on equity
+11.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$6.07B$5.44B$5.01B$4.46B$5.23B$4.39B$4.35B$3.72B$3.44B$2.96B
Cost of Revenue$1.33B$1.12B$978.40M$723.70M$1.25B$1.08B$1.11B$939.40M$875.30M$797.40M
Gross Profit$4.73B$4.32B$4.03B$3.74B$3.98B$3.31B$3.23B$2.78B$2.56B$2.17B
Operating Income$1.26B$1.38B$1.31B$1.50B$1.69B$897.60M$1.15B$748.20M$1.09B$751.20M
Net Income$1.07B$4.17B$1.40B$1.52B$1.50B
EPS (Diluted)$1.83$6.97$2.30$2.44$2.38$1.30$1.64$1.13$2.70$2.61
Total Assets$13.70B$13.06B$9.36B$8.29B$8.50B$7.24B$6.49B$5.32B$5.67B$4.51B
Total Liabilities$3.36B$2.99B$2.64B$2.49B$2.67B$2.66B
Shareholders' Equity$10.34B$10.00B$6.65B$5.81B$5.84B$4.57B$4.15B$3.14B$2.96B$2.62B
Cash & Equivalents$2.94B$3.05B$1.13B$769.00M$862.80M$1.18B$1.18B$714.10M$818.30M$930.10M
Operating Cash Flow$1.60B$542.30M$895.80M$1.22B$1.73B$1.05B$1.18B$926.70M$1.00B$704.40M
Capital Expenditures$260.20M$252.40M$253.00M$244.60M$325.80M$407.00M$254.40M$238.70M$168.10M$176.10M
Shares Outstanding585.80M599.30M609.40M624.20M631.20M631.90M636.70M640.90M215.90M217.80M